IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 95 filers reported holding IGM BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,000 | +4.0% | 6,203 | +13.9% | 0.00% | – |
| Q2 2023 | $50,000 | -25.4% | 5,445 | +11.3% | 0.00% | – |
| Q1 2023 | $67,000 | -26.4% | 4,892 | -9.3% | 0.00% | – |
| Q4 2022 | $91,000 | -8.1% | 5,395 | +24.6% | 0.00% | – |
| Q3 2022 | $99,000 | +167.6% | 4,329 | +110.5% | 0.00% | – |
| Q2 2022 | $37,000 | -43.9% | 2,057 | -17.8% | 0.00% | – |
| Q1 2022 | $66,000 | -38.3% | 2,503 | -31.4% | 0.00% | – |
| Q4 2021 | $107,000 | -94.3% | 3,651 | -87.3% | 0.00% | – |
| Q3 2021 | $1,890,000 | -20.6% | 28,744 | +0.4% | 0.00% | -100.0% |
| Q2 2021 | $2,381,000 | +33.6% | 28,621 | +23.2% | 0.00% | 0.0% |
| Q1 2021 | $1,782,000 | +901.1% | 23,229 | +1052.8% | 0.00% | – |
| Q4 2020 | $178,000 | +19.5% | 2,015 | +0.1% | 0.00% | – |
| Q3 2020 | $149,000 | +1.4% | 2,012 | 0.0% | 0.00% | – |
| Q2 2020 | $147,000 | +10.5% | 2,012 | -15.4% | 0.00% | – |
| Q1 2020 | $133,000 | +49.4% | 2,379 | +1.8% | 0.00% | – |
| Q4 2019 | $89,000 | – | 2,336 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |